Cognitive Resilience in Brain Health and Dementia Research
- PMID: 36093713
- PMCID: PMC10515194
- DOI: 10.3233/JAD-220755
Cognitive Resilience in Brain Health and Dementia Research
Abstract
With the expected rise in Alzheimer's disease and related dementias (ADRD) in the coming decades due to the aging population and a lack of effective disease-modifying treatments, there is a need for preventive strategies that may tap into resilience parameters. A wide array of resilience strategies has been proposed including genetics, socioeconomic status, lifestyle modifications, behavioral changes, and management of comorbid disease. These different strategies can be broadly classified as distinguishing between modifiable and non-modifiable risk factors, some of which can be quantified so that their clinical intervention can be effectively accomplished. A clear shift in research focus from dementia risk to addressing disease resistance and resilience is emerging that has provided new potential therapeutic targets. Here we review and summarize the latest investigations of resilience mechanisms and methods of quantifying resilience for clinical research. These approaches include identifying genetic variants that may help identify novel pathways (e.g., lipid metabolism, cellular trafficking, synaptic function, inflammation) for therapeutic treatments and biomarkers for use in a precision medicine-like regimen. In addition, innovative structural and molecular neuroimaging analyses may assist in detecting and quantifying pathological changes well before the onset of clinical symptoms setting up the possibility of primary and secondary prevention trials. Lastly, we summarize recent studies demonstrating the study of resilience in caregivers of persons living with dementia may have direct and indirect impact on the quality of care and patient outcomes.
Keywords: Alzheimer’s disease; biomarkers; brain health; cognition; cognitive reserve; dementia; neuroimaging; resilience.
Figures

Similar articles
-
Genetic variants and functional pathways associated with resilience to Alzheimer's disease.Brain. 2020 Aug 1;143(8):2561-2575. doi: 10.1093/brain/awaa209. Brain. 2020. PMID: 32844198 Free PMC article.
-
The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.Brain. 2019 Apr 1;142(4):1134-1147. doi: 10.1093/brain/awz037. Brain. 2019. PMID: 30851100 Free PMC article.
-
Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.BMC Med. 2019 Feb 27;17(1):47. doi: 10.1186/s12916-019-1283-z. BMC Med. 2019. PMID: 30808345 Free PMC article.
-
Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A Review of Completed and Prospective Studies.Nutrients. 2019 Sep 19;11(9):2258. doi: 10.3390/nu11092258. Nutrients. 2019. PMID: 31546966 Free PMC article. Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
From frailty to resilience: exploring adaptive capacity and reserve in older adults-a narrative review.Front Aging. 2025 Jul 1;6:1520842. doi: 10.3389/fragi.2025.1520842. eCollection 2025. Front Aging. 2025. PMID: 40665991 Free PMC article. Review.
-
Cognitive reserve is associated with education, social determinants, and cognitive outcomes among older American Indians in the Strong Heart Study.Commun Psychol. 2025 Jan 28;3(1):14. doi: 10.1038/s44271-025-00198-6. Commun Psychol. 2025. PMID: 39875529 Free PMC article.
-
Cortical excitability and the aging brain: toward a biomarker of cognitive resilience.Front Psychol. 2025 Feb 18;16:1542880. doi: 10.3389/fpsyg.2025.1542880. eCollection 2025. Front Psychol. 2025. PMID: 40040658 Free PMC article.
-
Global rural health disparities in Alzheimer's disease and related dementias: State of the science.Alzheimers Dement. 2023 Sep;19(9):4204-4225. doi: 10.1002/alz.13104. Epub 2023 May 23. Alzheimers Dement. 2023. PMID: 37218539 Free PMC article. Review.
-
APOE ε4 carrier status moderates the effect of lifestyle factors on cognitive reserve.Alzheimers Dement. 2024 Nov;20(11):8062-8073. doi: 10.1002/alz.14304. Epub 2024 Oct 11. Alzheimers Dement. 2024. PMID: 39392181 Free PMC article.
References
-
- (2022) 2022 Alzheimer’s disease facts and figures. Alzheimers Dement 18, 700–789. - PubMed
-
- Prince M, Guerchet M, Prina M (2013) The Global Impact of Dementia 2013-2050. Alzheimer’s Disease International, London.
-
- Hodes JF, Oakley CI, O’Keefe JH, Lu P, Galvin JE, Saif N, Bellara S, Rahman A, Kaufman Y, Hristov H, Rajji TK, Fosnacht Morgan AM, Patel S, Merrill DA, Kaiser S, Melendez-Cabrero J, Melendez JA, Krikorian R, Isaacson RS (2018) Alzheimer’s “prevention” vs. “risk reduction": Transcending semantics for clinical practice. Front Neurol 9, 1179. - PMC - PubMed
-
- Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413–446. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous